期刊文献+

新型抗抑郁药物的药物相互作用 被引量:6

Drug interactions of new antidepressants
原文传递
导出
摘要 新型抗抑郁药物的联合治疗及其与其他药物的联合应用可引起经细胞色素P450酶介导的多种药物的药动学改变,药物相互作用研究对临床合理用药具有重要意义。本文综述新型抗抑郁药物的药物相互作用,以期为临床用药提供参考。 New types of antidepressants are widely used as therapeutic alliance and often in combination with other medications. It may modify the pharmacokinetics mediated by cytochrome P450. The investigation on drug interactions has important significance for rational use of medicine. This paper reviews the drug interactions of the new antidepressants to provide a guideline for combination therapy of antidepressants in clinic.
作者 管晓波 陆峥
出处 《世界临床药物》 CAS 2012年第7期395-400,共6页 World Clinical Drug
关键词 抗抑郁药物 药物相互作用 选择性5-羟色胺再摄取抑制剂(SSRI) 氟西汀 帕罗西汀 细胞色素P450(CYP450) antidepressant drug interaction selective serotonin reuptake inhibitor (SSRI) fluoxetine paroxetine cytoehrome P450 (CYP450)
  • 相关文献

参考文献24

  • 1Preskorn S. Outpatient management of depression. 3rd editon [Jj. J Psychiatric Practice, 2010, 16 (1) : 68-69.
  • 2张石宁,姚辉,李继民,林红,陆水平,尚晓芳,王筱兰,孙静,谭俊华,韩钢.利培酮与氟西汀合并治疗精神分裂症的相互作用[J].中国临床药理学杂志,2009,25(1):11-13. 被引量:7
  • 3Muscatello MR, Spina E, Bandelow B, et al. Clinically relevant drug interactions in anxiety disorders [J]. Human Psycbopharmacol, 2012, 27 (3) : 239-253.
  • 4Lorena DIMA. Pharmacokinetic interacttions of new antipsychotics with other psychotics drugs [J]. Bull Transilv Univ Brasov, 2009, 2 (51) : SeriesVI.
  • 5毛智群,吕振雷,季萍.氯氮平合并氟伏沙明致氯氮平血清药物浓度增高一例[J].精神医学杂志,2011,24(2):85-85. 被引量:3
  • 6Castberg I, Skogvoll E, Spigset O. Quetiapine and drug interactions:evidence from a routine therapeutic drug monitoring service[J]. J Clin Psychiatry, 2007, 68 (10): 1540-1545.
  • 7Paulzen M, Finkelmever A, Grozinger M. Augmentative effects of fluvoxamine on duloxetine plasma levels in depressed patients [J]. Pharmacopsychiatry, 2011, 44 (7) : 317-323.
  • 8Maria RM, Edoardo S, Borwin B, et al. Clinically relevant drug interactions in anxiety disorders [J]. Hum Psychopharmacol, 2012, 27 (3) : 239-253.
  • 9Laurian V, Adina P, Maria N, et al. Effect of fluvoxamine on the pharmokinetics of zolpidem: a two-treatment period study in healthy volunteers [J]. Clin Exp Pharmacol Physiol, 2012, 39(1): 9-12.
  • 10Spina E, Avenoso A, Facciola G, et al. Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine [J]. Ther Drug Monit, 2001, 23 (1) : 223-227.

二级参考文献12

  • 1刘燕,李华芳,王慧芳,王克勋,高哲石,顾牛范.氯氮平、利培酮对精神分裂症病人血糖-胰岛素稳态的影响及相关因素分析[J].上海精神医学,2003,15(5):257-259. 被引量:33
  • 2毛佩贤,王智民,汤宜朗,蒋锋,蔡焯基.精神分裂症住院患者使用抗精神病药现状[J].临床精神医学杂志,2005,15(1):1-2. 被引量:29
  • 3Spina E, Avenoso A, Scordo MG, et al. Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction [J]. J Clin Psychopharmacol, 2002; 22:419 -423.
  • 4Spina E, Avenoso A, Facciola G, et al. Plasma concentrations of risperldone and 9 - hydroxyrisperldone during combined treatment with paroxetine[ J]. Ther Drug Monit, 2001 ; 23:223 - 227 .
  • 5Hiemke C, Peled A, Jabarin M, et al. Fluvoxamine augmentation of olanzapine in chronic schizophrenia: pharmacokinetic interactions and clinical effects[J]. J Clin Psychopharmacol,2002 ; 22:502 -506 .
  • 6Lu ML,Lane HY, Chen KP, et al. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients[J]. J Clin Psychopharmacol, 2000 ; 61:594 - 599 .
  • 7Wetzel H, Anghelescu I, Szegedi A, et al. Pharmacokinrtic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study [J]. J Clin Psychopharmacol, 1998 ; 18 : 2 - 9.
  • 8Bondolfi G, Eap CB, Bertschy G, et al. The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychiatric patients[J]. Pharmacopsychiatry, 2002; 35:50-56.
  • 9Aravagiri M, Yuwiler A, Marder SR . Distribution after repeated oral administration of different dose levels of risperidone and 9 - hydroxy - risperidone in the brain and other tissues of rat[ J]. Psychopharmacology, 1998 ; 139:356 - 363.
  • 10McNeely M J, Boyko E J, Weigle DS, et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans[ J ]. Diabetes Care, 1999 ; 22:65 - 70.

共引文献8

同被引文献81

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部